Jaekyung Cheon

机构：Ulsan College, Asan Medical Center, Moffitt Cancer Center, University of Ulsan, CHA University Bundang Medical Center, Ulsan University Hospital, CHA University · ORCID：0000-0001-8439-1739

发表论文 192 篇 · 总被引 3380 次 · h-index 32

代表论文

• Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment (2024 · Hepatology · 被引 59)
• Early Integrated Palliative Care in Patients With Advanced Cancer (2024 · JAMA Network Open · 被引 49)
• Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction (2024 · JAMA Oncology · 被引 39)
• Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trials (2025 · Journal of Hepatology · 被引 15)
• Lenvatinib versus Sorafenib Second-Line Therapy in Patients with Hepatocellular Carcinoma Progressed to Atezolizumab plus Bevacizumab: A Retrospective Real-World Study (2024 · Oncology · 被引 9)
• Impact of Etiology on Efficacy Outcomes with Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Retrospective Analysis in Asia-Pacific (2024 · Targeted Oncology · 被引 8)